G
Glenn M. Chertow
Researcher at Stanford University
Publications - 830
Citations - 94517
Glenn M. Chertow is an academic researcher from Stanford University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 128, co-authored 764 publications receiving 82401 citations. Previous affiliations of Glenn M. Chertow include University of Groningen & Fresenius Medical Care.
Papers
More filters
Journal ArticleDOI
Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD
Glenn M. Chertow,Pablo E. Pergola,Youssef M.K. Farag,Rajiv Agarwal,Susan Arnold,Gabriel Bako,Geoffrey A. Block,Steven K. Burke,Fausto P. Castillo,Alan G. Jardine,Zeeshan Khawaja,Mark J. Koury,Mark J. Koury,Eldrin F. Lewis,Tim Lin,Wenli Luo,Bradley J. Maroni,Kunihiro Matsushita,Peter A. McCullough,Patrick S. Parfrey,Prabir Roy-Chaudhury,Mark J. Sarnak,Amit Sharma,Bruce Spinowitz,Carol Tseng,James A. Tumlin,Dennis Vargo,Kimberly A. Walters,Wolfgang C. Winkelmayer,Janet Wittes,Kai-Uwe Eckardt +30 more
TL;DR: Vadadustat is an oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, a class of drugs that stabilize HIF and stimulate erythropoietin and red-cell production as discussed by the authors.
Journal ArticleDOI
Kidney dysfunction and fatal cardiovascular disease—an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study
Rajat Deo,Christina L. Wassel Fyr,Linda F. Fried,Anne B. Newman,Tamara B. Harris,Sara Angleman,Christie A. Green,Stephen B. Kritchevsky,Glenn M. Chertow,Steven R. Cummings,Michael G. Shlipak +10 more
TL;DR: Impaired kidney function is a strong predictor of cardiovascular death, particularly among participants without prior history of cardiovascular disease, and no significant association was found between low eGFR and cardiovascular death.
Journal ArticleDOI
How to Begin a Quality Improvement Project
Samuel A. Silver,Ziv Harel,Rory F. McQuillan,Adam V. Weizman,Alison Thomas,Glenn M. Chertow,Gihad Nesrallah,Chaim M. Bell,Christopher T. Chan +8 more
TL;DR: The real world utility of the quality improvement methods discussed are applied to a hypothetical quality improvement initiative that aims to promote home dialysis (home hemodialysis and peritoneal dialysis) and provide an example that kidney health care professionals can use to begin their own quality improvement projects.
Journal ArticleDOI
The case against calcium-based phosphate binders.
Sharon M. Moe,Glenn M. Chertow +1 more
TL;DR: Calcium-based phosphate binders should be avoided in many, if not most, patients who are undergoing dialysis, because of the compelling biologic plausibility that hyperphosphatemia and excess exogenous calcium administration can accelerate vascular calcification.
Journal ArticleDOI
Survival by dialysis modality in critically ill patients with acute kidney injury.
Kerry C. Cho,Jonathan Himmelfarb,Emil P. Paganini,T. Alp Ikizler,Sharon Soroko,Ravindra L. Mehta,Glenn M. Chertow +6 more
TL;DR: Data from the Program to Improve Care in Acute Renal Disease (PICARD), a multicenter observational study of AKI, provide no evidence for a survival benefit afforded by continuous renal replacement therapies (CRRT).